X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Biocon Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs BIOCON LTD - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

BIOCON LTD 
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD BIOCON LTD MERCK LTD/
BIOCON LTD
 
P/E (TTM) x 33.6 71.3 47.1% View Chart
P/BV x 3.8 6.7 56.1% View Chart
Dividend Yield % 0.8 0.2 406.8%  

Financials

 MERCK LTD   BIOCON LTD
EQUITY SHARE DATA
    MERCK LTD
Dec-16
BIOCON LTD
Mar-17
MERCK LTD/
BIOCON LTD
5-Yr Chart
Click to enlarge
High Rs1,0601,162 91.2%   
Low Rs623483 129.1%   
Sales per share (Unadj.) Rs632.4194.6 325.1%  
Earnings per share (Unadj.) Rs45.734.4 132.9%  
Cash flow per share (Unadj.) Rs62.348.3 129.1%  
Dividends per share (Unadj.) Rs11.001.00 1,100.0%  
Dividend yield (eoy) %1.30.1 1,074.8%  
Book value per share (Unadj.) Rs388.8241.9 160.8%  
Shares outstanding (eoy) m16.60200.00 8.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.34.2 31.5%   
Avg P/E ratio x18.423.9 77.0%  
P/CF ratio (eoy) x13.517.0 79.3%  
Price / Book Value ratio x2.23.4 63.7%  
Dividend payout %24.12.9 827.8%   
Avg Mkt Cap Rs m13,969164,440 8.5%   
No. of employees `0001.69.2 17.1%   
Total wages/salary Rs m1,4877,470 19.9%   
Avg. sales/employee Rs Th6,631.94,213.9 157.4%   
Avg. wages/employee Rs Th939.2809.0 116.1%   
Avg. net profit/employee Rs Th479.4745.2 64.3%   
INCOME DATA
Net Sales Rs m10,49838,911 27.0%  
Other income Rs m2421,571 15.4%   
Total revenues Rs m10,74140,482 26.5%   
Gross profit Rs m1,1359,795 11.6%  
Depreciation Rs m2762,772 9.9%   
Interest Rs m0260 0.0%   
Profit before tax Rs m1,1028,334 13.2%   
Minority Interest Rs m0163 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,616 21.2%   
Profit after tax Rs m7596,881 11.0%  
Gross profit margin %10.825.2 43.0%  
Effective tax rate %31.119.4 160.6%   
Net profit margin %7.217.7 40.9%  
BALANCE SHEET DATA
Current assets Rs m6,41040,477 15.8%   
Current liabilities Rs m8,82816,783 52.6%   
Net working cap to sales %-23.060.9 -37.8%  
Current ratio x0.72.4 30.1%  
Inventory Days Days5860 96.8%  
Debtors Days Days3883 46.3%  
Net fixed assets Rs m1,40645,073 3.1%   
Share capital Rs m1661,000 16.6%   
"Free" reserves Rs m6,28647,377 13.3%   
Net worth Rs m6,45548,377 13.3%   
Long term debt Rs m021,082 0.0%   
Total assets Rs m8,82893,942 9.4%  
Interest coverage xNM33.1-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.20.4 287.1%   
Return on assets %8.67.6 113.1%  
Return on equity %11.814.2 82.7%  
Return on capital %17.112.6 135.4%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m95912,988 7.4%   
Fx outflow Rs m2,6127,899 33.1%   
Net fx Rs m-1,6535,089 -32.5%   
CASH FLOW
From Operations Rs m1,0706,400 16.7%  
From Investments Rs m-750-4,985 15.0%  
From Financial Activity Rs m-150-1,775 8.4%  
Net Cashflow Rs m171-473 -36.1%  

Share Holding

Indian Promoters % 0.0 40.4 -  
Foreign collaborators % 51.8 20.6 251.5%  
Indian inst/Mut Fund % 18.2 8.4 216.7%  
FIIs % 1.0 10.7 9.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 19.9 146.2%  
Shareholders   28,591 109,995 26.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SANOFI INDIA  TORRENT PHARMA  PLETHICO PHARMA  CIPLA  ABBOTT INDIA  

Compare MERCK LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 400 Points; HDFC Twins Up 3%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels.

Related Views on News

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 18, 2018 03:35 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - UNICHEM LAB COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS